Eckert & Ziegler 2018: Revenue and earnings higher than expected
|
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Annual Results Berlin, 21 January 2019. Based on preliminary, unaudited calculations Eckert & Ziegler AG will generate sales of around 180 Mio. EUR and earnings per share of presumably 3.05 EUR for the financial year 2018. Earnings which already include the non-recurring expenses for the planned merger between EZAG and BEBIG will therewith exceed by approximately 10% the profit guidance of 2.80 EUR per share. The complete figures for the financial year 2018 will be published on 28 March 2019. Your contact:
21-Jan-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | 49 30 941084-138 |
| Fax: | 49 30 941084-112 |
| E-mail: | karolin.riehle@ezag.de |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| End of Announcement | DGAP News Service |